Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 18Rectal Neoplasms 7Colorectal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Neoplasms 3Breast Carcinoma In Situ 3Urinary Bladder Neoplasms 2Sarcoma 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colonic Neoplasms 2Bites and Stings 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stress, Psychological 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Seminoma 1Rhabdoid Tumor 1Retinoblastoma 1Prostatic Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasm, Residual 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Muscle Invasive Bladder Cancer 1Motor Activity 1

Interventions

Magnetic Resonance Spectroscopy 17Blood Specimen Collection 8Bevacizumab 8Temozolomide 7Radiotherapy 5Palliative Care 4Surgical Procedures, Operative 3Restraint, Physical 3Radiation 3Biopsy 3Yoga 2Standard of Care 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Psychosocial Intervention 2Perfusion Magnetic Resonance Imaging 2Mind-Body Therapies 2Magnetic Resonance Imaging 2Lomustine 2Gadolinium DTPA 2Elasticity Imaging Techniques 2Early Intervention, Educational 2Drug Therapy 2Diet Therapy 2Dexamethasone 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Glioblastoma × Neoadjuvant Therapy × Clear all
NCT01939574 2016-01-21

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Shandong Cancer Hospital and Institute

Phase NA Unknown
20 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡